Epidemiology of antibiotic resistance

Intensive Care Medicine, Supplement

Volumn 26, Issue 1, 2000, Pages

  Livermore, D M ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

Antibiotic resistance; Epidemiology

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL ENZYME; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; DISINFECTANT AGENT; GENTAMICIN; METICILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; TICARCILLIN; TIMENTIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GENETICS; CLOSTRIDIUM DIFFICILE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONFERENCE PAPER; ENTEROBACTER; FRANCE; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUTATION; SPAIN; TREATMENT OUTCOME; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MICROBIAL; HUMANS; MUTATION; SPECIES SPECIFICITY;

EID: 0034108824     PISSN: 09351701     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Standing Medical Advisory Committee (1998) The path of least resistance. Department of Health, London
2. Chen HY, Yuan M, Ibrahim-Elmogboul IB, Livermore DM (1995) National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa. J Antimicrob Chemother 35: 521-534
3. Archibald L, Phillips L, Monnet D et al. (1997) Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 24: 211-215
4. Woodford N, Johnson AP, Morrison D, Speller DC (1995) Current perspectives on glycopeptide resistance. Clin Microbiol Rev 8: 585-615
5. Oppenheim BA (1998) The changing pattern of infection in neutropenic patients. J Antimicrob Chemother 41 Suppl D:7-11
6. Spencer RC (1997) The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease. J Antimicrob Chemother 41 [Suppl C]:21-27
7. Humphreys H, Towner KJ (1997) Impact of Acinetobacter spp. in intensive care units in Great Britain and Ireland. J Hosp Inf 37: 281-286
8. Muder RR, Yu VL, Dummer JS et al (1987) Infections caused by Pseudomonas maltophilia: expanding clinical spectrum. Arch Intern Med 147: 1672-1674
9. Sanders CC, Sanders WE (1992) β-Lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 15: 824-839
10. Spratt BG (1994) Resistance to antibiotics mediated by target alterations. Science 264: 388-393
11. Klastersky J, Zinner SH, Calandra T et al. (1988) Empiric antimicrobial therapy for febrile, granulocytopenic cancer patients: lessons from four EORTC trials. Euro J Cancer Clin Oncol 24 [Suppl 1]:S35-S45
12. Davies JE (1997) Origins, acquisition and dissemination of antibiotic resistance determinants. In: Chadwick DJ, Goode J (eds) Antibiotic resistance: origins, evolution, selection and spread. Wiley, Chichester
13. Livermore DM. (1995) β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8: 557-584
14. Piddock LJ (1995) Mechanisms of resistance to fluoroquinolones: state-of-the-art 1992-1994. Drugs 49 [Suppl 2]:29-35
15. Nikaido H (1996) Multidrug efflux pumps of gram-negative bacteria. J Bacteriol 178: 5853-5859
16. Chow JW, Fine MJ, Shlaes DM et al. (1991) Enterobacter bacteraemia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 115: 585-590
17. Livermore DM, Yuan M (1996) Antibiotic resistance and production of extended-spectrum β-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 38: 409-424
18. Hibbert-Rogers LC, Heritage J, Todd N, Hawkey PM (1994) Convergent evolution of TEM-26, a β-lactamase with extended-spectrum activity. J Antimicrob Chemother 33: 707-720
19. Xiang X, Shannon K, French G (1997) Mechanism and stability of hyperproduction of the extended-spectrum β-lactamase SHV-5 in Klebsiella pneumoniae. J Antimicrob Chemother 40: 525-532
20. Petit A, Gerbaud G, Sirot D et al. (1990) Molecular epidemiology of TEM-3 (CTX-1) β-lactamase. Antimicrob Agents Chemother 34: 219-224
21. Schiappa DA, Hayden MK, Matushek MG et al (1996) Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 174: 529-536
22. Roberts MC (1997) Genetic mobility and distribution of tetracycline resistance determinants. Ciba Foundation Symposium 207: 206-218
23. Hall RM, Collis CM (1995) Mobile genes and integrons: capture and spread of genes by site-specific recombination. Mol Microbiol 15: 593-600
24. Chiew YF, Yeo SF, Hall LMC, Livermore DM (1998) Can susceptibility to an antimicrobial be restored by halting its use? The case of streptomycin versus Enterobacteriacae. J Antimicrob Chemother 41: 247-251
25. Yuan M, Aucken H, Hall LMC et al (1998) Epidemiological typing of klebsiellae with extended-spectrum β-lactamases from European intensive care units. J Antimicrob Chemother 41: 527-539
26. Bouma JE, Lenski RE (1998) Evolution of a bacteria/plasmid association. Nature 335: 351-352
27. Department of Health and Social Security (1988) Guidance on the control of infection in hospitals prepared by the joint DHSS/PHLS Hospital Infection Working Group ("The Cooke Report"). Department of Health and Social Security, London
28. Anon (1999) Methicillin resistance in Staphylococcus aureus isolated from blood in England and Wales: 1994 to 1998. CDR Weekly 9: 65-68
29. Cookson B, Morrison D, Marples R (1997) Antibiotic resistance. Nosocomial gram-positive infection. J Med Microbiol 46: 439-442
30. Pitt TL, Kaufmann ME, Patel PS et al (1996) Characterization and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the UK and Ireland. J Med Microbiol 44: 203-210
31. French GL, Shannon KP, Simmons N (1996) Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactam-β-lactamase inhibitor combinations by hyperproduction of SHV-5 β-lactamase. J Clin Microbiol 34: 358-363
32. Doern GV, Brueggemann AB, Blocker M et al (1998) Clonal relationships among high-level penicillin-resistant Streptococcus pneumoniae in the United States. Clin Infect Dis 27: 757-761
33. Working Party (1998) Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. J Hosp Infect 38: 235-290
34. di Martino P, Livrelli V, Sirot D et al (1996) A new fimbrial antigen harboured by CAZ-5/SHV-4-producing Klebsiella pneumoniae strains involved in nosocomial infections. Infect Immun 64: 2266-2273
35. Livermore DM (1998) β-Lactamase-mediated resistance and opportunities for its control. J Antimicrob Chemother 41 [Suppl D]:25-41
36. Trenholme GM, Kaplan RL, Karakuis PH et al (1989) Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates. J Clin Microbiol 27: 1342-1345
37. Betts RF, Valenti WM, Chapman SW et al (1984) Five-year surveillance of aminoglycoside usage in a university hospital. Ann Intern Med 100: 219-222
38. Rahal JJ, Urban C, Horn D et al (1998) Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280: 1233-1237
39. Bradley SJ, Wilson ALT, Allen MC et al (1999) The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage. J Antimicrob Chemother 43: 261-266